We are monitoring the impact of COVID-19 on Latin America Monoclonal Antibody Therapy Market Get in touch with us for detailed analysis Know More
Pulished Date October, 2021
ID: 12289
Share on
Share on

Latin America Monoclonal antibody therapy Market Research Report - Segmented By Type, Application, Distribution channel, and Country (Brazil, Argentina, Chile, Mexico and Rest of Latin America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast | 2021 to 2026

Pulished: October, 2021
ID: 12289
Pages: 145

Latin America Monoclonal Antibody Therapy Market Size (2021 to 2026)

The Latin America monoclonal antibody therapy market is expected to reach USD 28.56 billion in 2026, up from USD 12.90 billion in 2021, at a CAGR of 17.22% over the forecast period 2021-2026.

Monoclonal antibodies (mAbs), a type of monospecific antibody (protective body inflammatory response), are made up of identical antibody molecules and are produced by a single cell clone or cell line. The mAbs have brought about a fundamental change in the pharmaceutical and biotechnology industries, and in the future, they are also expected to play a crucial role in clinical protocol with the further development of these molecular agents.

Monoclonal antibodies are proteins cultivated in the laboratory that mimic the ability of the immune system to fight harmful pathogens such as viruses. Many monoclonal antibodies that specifically target the SARS-CoV-2 virus, are currently driving the market owing to the pandemic stressing out the world.

Monoclonal antibodies are also used to fight against cancer and cancer-causing agents in the body. Globally, the total number of people alive is estimated at 46 million. Additionally, the therapeutic use of monoclonal antibodies is exhibited to show lesser side effects in the body, they have been shown to be a great cancer treatment alternative to drugs and chemotherapy. The World Health Organization (WHO) reports that cancer is the leading cause of death around the globe. According to 2012 statistics, it was reported that 9 million deaths were seen worldwide and nearly 65,000 in Argentina alone. Cancer deaths are expected to increase by over 15 million by 2030. The growing trend for precision medicine and custom-made monoclonal antibodies has boosted the Latin American market for the past several years. The plethora of benefits associated with monoclonal antibody drugs is expected to increase demand in the years to come.

The other factors driving the Latin American monoclonal antibody therapy market are the increasing incidence of chronic diseases and genetic diseases due to mutations and increasing genomics R&D activities. According to the World Health Organization, diabetes increased to 20 million new cases and 15 million undiagnosed cases in 2018. Research and development of monoclonal antibodies against multiple diseases and technologies such as the antibodies vaccinations, formulation of bio proteins, are expected to provide significant market opportunities during the anticipated period.

However, higher costs with the research, development, and production and stringent regulatory authorities that result in lengthy approval procedures and clinical trial periods will restrict the market growth. These monoclonal antibodies products are technique sensitive and require skilled labor, lack of which leads to wastage of expenses and resources. This, to some extent, will hamper the Latin American monoclonal antibody market. Moreover, certain regions in Latin America have developing economies, where there are poor healthcare facilities, this restraint the market growth.

This research report on the Latin America monoclonal antibody therapy market has been segmented and sub-segmented into the following categories:

By Type:

  • Human mAb

  • Humanized mAb

  • Chimeric mAb

  • Murine mAb

By Application:

  • Cancer

  • Autoimmune Diseases

By Distribution Channel:

  • Hospital Pharmacy Retail Pharmacy

By Country:

  • Brazil
  • Argentina
  • Chile
  • Mexico
  • Rest of Latin America

In 2020, the Latin America monoclonal antibody therapy market was valued at USD 2 billion, growing at an impressive CAGR of 3.9%. Brazil is the dominant player in the LATAM monoclonal antibody therapy market and can be attributed to developing healthcare infrastructure, easy availability of the products, and high incidence of cancer in the region. In addition, well-established reimbursement policies, growing healthcare awareness contributes to growth in the Brazilian market. The growing number of pharmaceutical and bioscience companies for these monoclonal therapies will also bode well for market growth in this region.

In 2019, the market in Mexico was worth $ 1.8 billion and this value is expected to increase further in the years to come. The market in Mexico will grow thanks to the presence of pharmaceutical ties with international companies, especially with the U.S. Moreover, the increasing prevalence of diseases such as cancer and communicable diseases will help in the growth of the regional market.

After Brazil and Mexico, Argentina accounted for the third-largest share of the Latin America monoclonal antibody therapy market, followed by Columbia and Ecuador. Growth in these markets is primarily driven by several factors, such as developing research and development, the launch of new products, the growing incidence of chronic disorders, early entry into the market, and unmet market needs. While rest of Latin America will show a slow sluggish growth rate during the projected period owing to the lack of government support for infection control and management and cheaper drugs.

KEY MARKET PLAYERS:

Pfizer Inc., Novartis AG, Bayer AG, Sanofi S.A., CASI Pharmaceuticals, Eli Lilly and Co., Merck & Co., Inc., Changchun Zhongyingfeng Science And Technology Co., Ltd, Hangzhou Immuno Biotech Co. Ltd, Nantong Egens Biotechnology Co. Ltd are some of the dominating companies in the Latin America monoclonal antibody therapy market.

1. Introduction                                   

            1.1 Market Definition            

            1.2 Scope of the report                     

            1.3 Study Assumptions                      

            1.4 Base Currency, Base Year and Forecast Periods             

2. Research Methodology                             

            2.1 Analysis Design                

            2.2 Research Phases              

                        2.2.1 Secondary Research     

                        2.2.2 Primary Research          

                        2.2.3 Data Modelling 

                        2.2.4 Expert Validation          

            2.3 Study Timeline                 

3. Report Overview                            

            3.1 Executive Summary                     

            3.2 Key Inferencees               

4. Market Dynamics                           

            4.1 Impact Analysis                

                        4.1.1 Drivers  

                        4.1.2 Restaints

                        4.1.3 Opportunities   

            4.2 Regulatory Environment              

            4.3 Technology Timeline & Recent Trends                

5. Competitor Benchmarking Analysis                                  

            5.1 Key Player Benchmarking            

                        5.1.1 Market share analysis   

                        5.1.2 Products/Service          

                        5.1.3 Regional Presence        

            5.2 Mergers & Acquistion Landscape            

            5.3 Joint Ventures & Collaborations              

6. Market Segmentation                                

            6.1 Latin America Monoclonal Antibody Therapy Market - By Type:                       

                        6.1.1 Human mAb      

                        6.1.2 Humanized mAb

                        6.1.3 Chimeric mAb   

                        6.1.4 Murine mAb      

                        6.1.5 Market Size Estimations & Forecasts (2021-2026)      

                        6.1.6 Y-o-Y Growth Rate Analysis      

                        6.1.7 Market Attractiveness Index    

            6.2 Latin America Monoclonal Antibody Therapy Market -By Application:             

                        6.2.1 Cancer   

                        6.2.2 Autoimmune Diseases  

                        6.2.3 Market Size Estimations & Forecasts (2021-2026)      

                        6.2.4 Y-o-Y Growth Rate Analysis      

                        6.2.5 Market Attractiveness Index    

            6.3 Latin America Monoclonal Antibody Therapy Market -By Distribution Channel:                      

                        6.3.1 Hospital Pharmacy Retail Pharmacy    

                        6.3.2 Online Pharmacy          

                        6.3.3 Market Size Estimations & Forecasts (2021-2026)      

                        6.3.4 Y-o-Y Growth Rate Analysis      

                        6.3.5 Market Attractiveness Index    

7. Geographical Landscape                            

            7.1 Latin America                   

                        7.1.1 By Country        

                                    7.1.1.1 Brazil

                                    7.1.1.2 Argentina

                                    7.1.1.3 Mexico

                                    7.1.1.4 Rest of Latin America

                        7.1.2 By Type 

                        7.1.3 By Application   

                        7.1.4 By Distribution Channel:           

8. Key Player Analysis                        

            8.1 Pfizer Inc.             

                        8.1.1 Business Description    

                        8.1.2 Products/Service          

                        8.1.3 Financials          

                        8.1.4 SWOT Analysis  

                        8.1.5 Recent Developments  

                        8.1.6 Analyst Overview          

            8.2 Novartis AG                      

            8.3 Bayer AG              

            8.4 Sanofi S.A.            

            8.5 CASI Pharmaceuticals                  

            8.6 Eli Lilly and Co.                 

            8.7 Merck & Co., Inc.             

            8.8 Changchun Zhongyingfeng Science And Technology Co., Ltd                 

            8.9 Hangzhou Immuno Biotech Co. Ltd                     

            8.10 Nantong Egens Biotechnology Co. Ltd              

9. Market Outlook & Investment Opportunities                               

10.Appendix                           

            List of Tables              

            List of Figures  

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and also identify the areas that are still untapped. 

  • The segment-level analysis in terms of type, application, distribution channel, and region along with market size forecasts and estimations to detect key areas of industry growth in detail.

  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.

  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.

  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.

  • A comprehensive list of key market players along with their product portfolio, current strategic interests, essential financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment.

  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies

  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.

  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations with a strong financial foothold in the market.

  1. Latin America Monoclonal Antibody Therapy Market By Type, From 2021 to 2026 ( USD Billion )

  2. Latin America Human mAb Market By Region, From 2021 to 2026 ( USD Billion )

  3. Latin America Humanized mAb Market By Region, From 2021 to 2026 ( USD Billion )

  4. Latin America Chimeric mAb Market By Region, From 2021 to 2026 ( USD Billion )

  5. Latin America Murine mAb Market By Region, From 2021 to 2026 ( USD Billion )

  6. Latin America Monoclonal Antibody Therapy Market By Application, From 2021 to 2026 ( USD Billion )

  7. Latin America Cancer Market By Region, From 2021 to 2026 ( USD Billion )

  8. Latin America Autoimmune Diseases Market By Region, From 2021 to 2026 ( USD Billion )

  9. Latin America Monoclonal Antibody Therapy Market By Distribution Channel, From 2021 to 2026 ( USD Billion )

  10. Latin America Hospital Pharmacy Retail Pharmacy Market By Region, From 2021 to 2026 ( USD Billion )

  11. Latin America Online Pharmacy Market By Region, From 2021 to 2026 ( USD Billion )

  12. Brazil Monoclonal Antibody Therapy Market By Type, From 2021 to 2026 ( USD Billion )

  13. Brazil Monoclonal Antibody Therapy Market By Application, From 2021 to 2026 ( USD Billion )

  14. Brazil Monoclonal Antibody Therapy Market By Distribution Channel, From 2021 to 2026 ( USD Billion )

  15. Argentina Monoclonal Antibody Therapy Market By Type, From 2021 to 2026 ( USD Billion )

  16. Argentina Monoclonal Antibody Therapy Market By Application, From 2021 to 2026 ( USD Billion )

  17. Argentina Monoclonal Antibody Therapy Market By Distribution Channel, From 2021 to 2026 ( USD Billion )

  18. Mexico Monoclonal Antibody Therapy Market By Type, From 2021 to 2026 ( USD Billion )

  19. Mexico Monoclonal Antibody Therapy Market By Application, From 2021 to 2026 ( USD Billion )

  20. Mexico Monoclonal Antibody Therapy Market By Distribution Channel, From 2021 to 2026 ( USD Billion )

  21. Rest of Latin America Monoclonal Antibody Therapy Market By Type, From 2021 to 2026 ( USD Billion )

  22. Rest of Latin America Monoclonal Antibody Therapy Market By Application, From 2021 to 2026 ( USD Billion )

  23. Rest of Latin America Monoclonal Antibody Therapy Market By Distribution Channel, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample